Design and synthesis of novel CCR3 antagonists

…, JH Hogg, J Collier, RS Wilhelm, C Soderberg

Index: Gong, Leyi; Hogg, J. Heather; Collier, James; Wilhelm, Robert S.; Soderberg, Carol Bioorganic and Medicinal Chemistry Letters, 2003 , vol. 13, # 20 p. 3597 - 3600

Full Text: HTML

Citation Number: 13

Abstract

As part of our investigation into the development of potent CCR3 antagonists, a series of piperidine analogues was designed and prepared. Exploration of the piperidine core examined both the basicity and the location of a nitrogen, as well as conformational variants. The bicyclo-piperidine 24c was found to be the most potent inhibitor of CCR3 with an IC50 of 0.0082 μM in the binding assay and 0.0024 μM in the chemotaxis assay.

Related Articles:

Conformational properties of O-alkylated benzamides

[Prabhakaran, Panchami; Azzarito, Valeria; Jacobs, Tia; Hardie, Michaele J.; Kilner, Colin A.; Edwards, Thomas A.; Warriner, Stuart L.; Wilson, Andrew J. Tetrahedron, 2012 , vol. 68, # 23 p. 4485 - 4491]

Specific Detection and Imaging of Enzyme Activity by Signal??Amplifiable Self??Assembling 19F MRI Probes

[Matsuo, Kazuya; Kamada, Rui; Mizusawa, Keigo; Imai, Hirohiko; Takayama, Yuki; Narazaki, Michiko; Matsuda, Tetsuya; Takaoka, Yousuke; Hamachi, Itaru Chemistry - A European Journal, 2013 , vol. 19, # 38 p. 12875 - 12883]

Synthesis, structure–activity relationship, and p210 bcr-abl protein tyrosine kinase activity of novel AG 957 analogs

[Kaur, Gurmeet; Narayanan, Ven L.; Risbood, Prabhakar A.; Hollingshead, Melinda G.; Stinson, Sherman F.; Varma, Ravi K.; Sausville, Edward A. Bioorganic and Medicinal Chemistry, 2005 , vol. 13, # 5 p. 1749 - 1761]

More Articles...